Following CE Mark approval earlier this month, Medovex received its first 3 commercial orders for the DenerveX™ system from distributors in Germany, Italy and the U.K.
DenerveX comprises a single-use device and power generator. Intended for the treatment of Facet Joint Syndrome, the system denervates and removes capsular tissue from the facet joint in a single procedure that combines deburring action and RF ablation. The burr removes targeted synovial membranes and joint surfaces, while heat ablation destroys tissue and removes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue.
Following CE Mark approval earlier this month, Medovex received its first 3 commercial orders for the DenerveX™ system from distributors in Germany, Italy and the U.K.
DenerveX comprises a single-use device and power generator. Intended for the treatment of Facet Joint Syndrome, the system denervates and removes capsular tissue from the facet...
Following CE Mark approval earlier this month, Medovex received its first 3 commercial orders for the DenerveX™ system from distributors in Germany, Italy and the U.K.
DenerveX comprises a single-use device and power generator. Intended for the treatment of Facet Joint Syndrome, the system denervates and removes capsular tissue from the facet joint in a single procedure that combines deburring action and RF ablation. The burr removes targeted synovial membranes and joint surfaces, while heat ablation destroys tissue and removes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue.
Copy to clipboard 
